Angelo Semeraro
Martina Franca, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Very short-term monitoring of Romosozumab longitudinal effects in a cohort of postmenopausal women by means of Radiofrequency Echographic Multi-Spectrometry (REMS) technology.
Journal: Aging clinical and experimental research
Published: March 13, 2026
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.
Journal: Journal of clinical medicine
Published: March 09, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib.
Journal: Rheumatology (Oxford, England)
Published: February 07, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.
Journal: Therapeutic advances in musculoskeletal disease
Published: October 23, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
Journal: Arthritis research & therapy
Published: March 16, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry.
Journal: Clinical and experimental rheumatology
Published: February 24, 2024
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry.
Journal: European journal of clinical investigation
Published: July 13, 2022
Discontinuation of low-dose thiazide treatment in hypertensive patients associated with improvement in glycemic profile.
Journal: Internal and emergency medicine
Published: May 19, 2022
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Journal: RMD open
Published: November 13, 2020
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Journal: Rheumatology international
Published: May 23, 2019
Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Journal: Clinical drug investigation
Published: April 04, 2019
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.
Journal: Clinical and experimental rheumatology
Published: September 02, 2018
Last Updated: 09/26/2026